DAILY DIALECTIC
August 03, 2009
"MedImmune, part of global drugmaker AstraZeneca, is one of five companies with a contract to sell a vaccine for the H1N1 virus, originally known as swine flu, to the federal government. MedImmune's flu vaccine differs from the others in two major ways: It is delivered via nasal spray instead of an injection and is made with a live but weakened virus instead of a dead one..."

  • Washington Post: MedImmune Ramps Up H1N1 Vaccine; Company uses live H1N1 virus in vaccines